New York-based AngioDynamics is now facing a patent infringement lawsuit from Bard (and Bard Peripheral Vascular) because apparently the company’s Small Port vascular device and other inplantable power-injectable port products violate three patents established by Bard.
A judge in Delaware, Sue Robinson, validated the suit this week. AngioDynamics is asking that the case be transferred to where Bard makes it devices in Utah because neither company is based in Delaware.
As MassDevice reported, there was a previous suit filed in 2012 and remains present until the U.S. Patent & Trademark Office board issues a final ruling on the AngioDynamics challenges to the patents.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Judge Robinson declined a request to change venues then as well, citing that traditionally the plaintiff is the one who has more of a say in determining the location of the proceedings.
Photo: Flickr user Brian Turner